Development of a Predictive Model for Mortality in Hospitalized Patients With COVID-19

Yuanyuan Niu1, Zan Zhan2, Jianfeng Li3

  • 1Department of Respiratory Medicine, The Eastern Hospital of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong Province, China.

Insights

Early identification of high-risk COVID-19 patients is crucial. A nomogram using SOFA score, diabetes, and LDH levels accurately predicts mortality risk, aiding clinical decisions for novel coronavirus disease 2019.

Area of Science:

  • Medical research
  • Infectious diseases
  • Critical care medicine

Background:

  • Early identification of patients with high mortality risk for novel coronavirus disease 2019 (COVID-19) is critical.
  • Clinical characteristics and outcomes of COVID-19 patients require detailed analysis to identify mortality predictors.

Purpose of the Study:

  • To identify risk factors associated with in-hospital death in COVID-19 patients.
  • To develop a predictive model (nomogram) for assessing the risk of mortality in COVID-19 patients.

Main Methods:

  • Retrospective study of 150 COVID-19 patients (January 23 - March 5, 2020).
  • Comparison of clinical characteristics and outcomes between survivors and non-survivors.
  • Univariable and multivariable logistic regression analysis to identify risk factors for in-hospital death, followed by nomogram construction.

Main Results:

  • Multivariable analysis identified higher Sequential Organ Failure Assessment (SOFA) score, diabetes, and lactate dehydrogenase (LDH) > 245 U/L as significant predictors of in-hospital death.
  • The developed nomogram demonstrated good accuracy in predicting mortality risk, with an Area Under the Curve (AUC) of 0.970.

Conclusions:

  • The study successfully developed a nomogram for early identification of COVID-19 patients at high risk of fatal outcomes.
  • This predictive tool can aid clinicians in timely intervention and management of critically ill COVID-19 patients.
Abstract

Related Concept Videos

Kaplan-Meier Approach01:24

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
399
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
259
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
407
Actuarial Approach01:20

Actuarial Approach

The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
194
Cancer Survival Analysis01:21

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
529
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
350